AUGUST 2022LIFE SCIENCES REVIEW6Over the past few years, the biotech industry in Canada has been on a continuous growth trajectory. It has become a favorite destination for international collaborations and partnerships. This has been possible owing to the country's long-standing reputation for high-quality research. No wonder, the biotech and life sciences sector in Canada is witnessing a significant amount of investment. According to reports, in the first three months of 2022, Canadian life sciences companies accumulated a considerable amount of venture capital investment--three times more than what they received in the fourth quarter of 2021. Despite such massive investments, the biotech sector is facing a major roadblock--talent shortage. Given the steep competition in the global biotech market, it has become a real challenge for organizations to retain key talent. Organizations are striving to eliminate this quandary and keep the wheel of innovation rolling by bringing foreign talents. There is no way to deny that the government is also helping by streamlining the immigration policies, even after the scramble of the pandemic. More importantly, the country also offers world-class academic institutions, wide-reaching research networks, and multiple partnership opportunities. All these endeavors won't bring positive outcomes overnight; it will take time. But, with all the efforts being made, it will not be an overstatement that Canada will celebrate remarkable scientific achievements in the forthcoming days that will change the face of the global biotech industry.In this edition, we aim to highlight the changing facets of Canada's biotech and life sciences sector and provide our readers with insights into the ongoing innovations in this arena.Let us know your thoughts.EDITORIALThe Thriving Biotech Sector of CanadaCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com AUGUST - 1 - 2022, Vol 03, Issue - 16 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comVictor Cruz Aaron PierceCarolynn WaltersShirley FaithRussell ThomasCatalina Joseph Clara Matthew
< Page 5 | Page 7 >